The Claim
In pediatric renal transplant recipients who are not receiving calcineurin inhibitors, sirolimus trough levels show a strong correlation with total drug exposure (AUC), with an r² value of 0.84 and a p-value less than 0.001, indicating that trough concentration monitoring can be used to estimate overall drug burden.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For kids who've had a kidney transplant and are taking a drug called sirolimus (but not certain other drugs), checking the lowest level of the drug in their blood helps doctors figure out how much of the drug their body is getting overall.
See the scientific wording
In pediatric renal transplant recipients not receiving calcineurin inhibitors, sirolimus trough levels are strongly correlated with total drug exposure (AUC) (r² = 0.84, p < 0.001), supporting the use of trough monitoring to estimate overall drug burden.
What the research says
1 studyThe study looked at kids who had kidney transplants and were taking sirolimus without certain other drugs, and found that checking their blood levels at the lowest point (trough) reliably shows how much of the drug is in their body overall.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.